ODE III deputy director appointed
Executive Summary
Office of Drug Evaluation III Deputy Director Julie Beitz, MD, brings experience coordinating drug risk management programs to new post, effective March 23. Beitz was director of FDA's Division of Drug Risk Evaluation within the Office of Drug Safety since February 2000, and first joined FDA in 1994 as a medical officer in the Division of Oncology & Pulmonary Drug Products...